CTi Biopharma Corp Valuation

Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. CTi Biopharma Corp prevailing Real Value cannot be determined due to lack of data. The current price of CTi Biopharma Corp is $0.0. Our model approximates the value of CTi Biopharma Corp from analyzing the firm fundamentals such as Return On Equity of -10.19, current valuation of 1.26 B, and Profit Margin of (0.91) % as well as examining its technical indicators and probability of bankruptcy.

CTi Biopharma Total Value Analysis

CTi Biopharma Corp is currently forecasted to have valuation of 1.26 B with market capitalization of 1.2 B, debt of 49.96 M, and cash on hands of 81.64 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CTi Biopharma fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
1.26 B
1.2 B
49.96 M
81.64 M

CTi Biopharma Investor Information

About 83.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.54. CTi Biopharma Corp last dividend was issued on the 3rd of January 2017. The entity had 1:10 split on the 3rd of January 2017. Based on the key measurements obtained from CTi Biopharma's financial statements, CTi Biopharma Corp is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.

CTi Biopharma Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CTi Biopharma has an asset utilization ratio of 42.84 percent. This indicates that the Company is making $0.43 for each dollar of assets. An increasing asset utilization means that CTi Biopharma Corp is more efficient with each dollar of assets it utilizes for everyday operations.

CTi Biopharma Ownership Allocation

CTi Biopharma holds a total of 131.88 Million outstanding shares. The majority of CTi Biopharma Corp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in CTi Biopharma Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in CTi Biopharma. Please pay attention to any change in the institutional holdings of CTi Biopharma Corp as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

CTi Biopharma Profitability Analysis

The company reported the previous year's revenue of 53.95 M. Net Loss for the year was (92.99 M) with profit before overhead, payroll, taxes, and interest of 50.43 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CTi Biopharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CTi Biopharma and how it compares across the competition.

CTi Biopharma Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding114.7 M
Forward Price Earnings26.5957
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Consideration for investing in CTi Stock

If you are still planning to invest in CTi Biopharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CTi Biopharma's history and understand the potential risks before investing.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format